IL17A and inflammatory bowel disease: 33411953 33411953 Petitpain N, D’Amico F, Yelehe-Okouma M, Jouzeau J‐Y, Netter P, Peyrin-Biroulet L, Gillet P (2021) IL-17 Inhibitors and Inflammatory Bowel Diseases: A Postmarketing Study in Vigibase.